DSP-0390, an investigational new agent developed by Cambridge, Massachusetts-based Sumitomo Dainippon Pharma Oncology, is an inhibitor of emopamil-binding
/PRNewswire/ John Theurer Cancer Center at Hackensack University Medical Center, New Jersey s top ranked cancer center, according to U.S. News & World.
HMH to partner with Foundation for Health Advancement to increase innovative research roi-nj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from roi-nj.com Daily Mail and Mail on Sunday newspapers.